Table 1
| Â | Â | Group 1 | Group 2 | Group 3 | Group 4 |
|---|---|---|---|---|---|
sFasL (ng/ml) | Mean±SD | 0.20±0.14 | 0.24±0.16 | 0.22±0.16 | 0.19±0.21 |
| Â | Median | 0.27 | 0.20 | 0.18 | 0.10 |
CD3+/CD4+ cells* | Mean±SD | 1508±1230 | 1761±824 | 918±552 | 1240±347 |
| Â | Median | 1026 | 1604 | 741 | 1212 |
CD3+/CD8+ cells* | Mean±SD | 1735±1839 | 888±463 | 509±355 | 723±252 |
| Â | Median | 1376 | 910 | 407 | 624 |
CD19+ cells* | Mean±SD | 622±322 | 1049±659 | 195±181 | 535±286 |
| Â | Median | 630 | 834 | 132 | 489 |
CD3)/CD16+/CD56+(NK cells)* | Mean±SD | 151-980 | 264-3009 | 20-487 | 103-1241 |
|  | Median | 250±238 | 181±111 | 94±34 | 253±235 |